Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time?

IF 9.3 1区医学 Q1 ONCOLOGY European urology oncology Pub Date : 2025-06-01 Epub Date: 2025-03-14 DOI:10.1016/j.euo.2025.02.014

Raquibul Hannan , Veronica Mollica , Carlotta Palumbo , Selcuk Erdem

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

立体定向放射治疗原发性肾细胞癌：准备好了吗？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format

期刊最新文献

Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival. Methodological Considerations on Causal Interpretability of the IRRADIaTE Registry. Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks. DaBlaCa-13 Study: Five-year Follow-up from the Randomized Controlled Trial of Chemoresection with Intravesical Mitomycin C in Recurrent Ta Non-muscle-invasive Bladder Cancer. Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).